Catalyst Healthcare, founded in Worcester, Massachusetts, is a prominent provider of innovative healthcare solutions dedicated to improving patient outcomes and accessibility. The company specializes in a variety of services, including telemedicine, personalized care management, and health technology integration that empower patients and streamline healthcare delivery.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| CATHEA 5.87% 2030-12-31 GBPCatalyst Healthcare (Worcester) | United Kingdom | 2030-12-31 | 5.870 | 5.71 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Catalyst Healthcare has been active in the bond market since its inception, with its first issuance occurring in 2010 to support expansion initiatives. Notably, the company issued $250 million in bonds in 2021, aimed at enhancing facility infrastructure and technology upgrades. Currently, these bonds yield approximately 4.2%, aligning closely with industry averages while offering investors attractive returns. Catalyst's bonds feature a call option, providing increased flexibility for corporate financing strategies. Recent news highlights their commitment to sustainable healthcare practices, further enhancing their market position.